Skip to content

Effect of oral zinc on hyperbilirubinemia on LBW premature neonates admitted in NICU

Effect of oral zinc on hyperbilirubinemia on LBW premature neonates admitted in NICU

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201401041162N22
Enrollment
60
Registered
2015-07-31
Start date
2014-05-24
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: low birth weight. Condition 2: hyperbilirubinemia. Other low birth weight Neonatal jaundice associated with preterm delivery

Interventions

Intervention 1: in cases: zinc sulfate 10 mg BID as per oral for 5 days or placebo twice time/ day. Intervention 2: in controls:Placebo.
Treatment - Drugs
Placebo
in cases: zinc sulfate 10 mg BID as per oral for 5 days or placebo twice time/ day
in controls:Placebo

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Days to 28 Days

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Babies who admitted to NICU of Imam Reza Hospital; birth weight 1500-2500 gm; Exclusion Criteria: jaundice in day one; hemolysis with positive comb’s test; severely ill babies; infection and sepsis based on clinical and lab test; those with ventilator support; five minutes apgar less than 7; congenital anomalies; intolerance of feeding ; intolerance of zinc supplementation ( gastrointestinal hemorrhage and residue, suddenly getting poor general condition) ; and mothers with sing of high or low level of serum zinc

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Decreasing of serum bilirubin. Timepoint: befor intervention and 12,24,48,72 , 96 and 120 hours after intervention. Method of measurement: measurment of serum bilirubin (diazo method).

Secondary

MeasureTime frame
Tereatment of jaundice of neonate. Timepoint: befor intervention and 24,48,72 , 96 and 120 hours after intervention. Method of measurement: decreasing of jaundice and bilirubin level in blood serum.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Ashraf Mohammadzadeh

Neonatal Research Center

mohamadzadeha@mums.ac.ir+98 51 1852 1121

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026